[PDF][PDF] A combined cell and gene therapy approach for homotopic reconstruction of midbrain dopamine pathways using human pluripotent stem cells

N Moriarty, CW Gantner, CPJ Hunt, CM Ermine… - Cell Stem Cell, 2022 - cell.com
Midbrain dopamine (mDA) neurons can be replaced in patients with Parkinson's disease
(PD) in order to provide long-term improvement in motor functions. The limited capacity for …

A combined cell and gene therapy approach for homotopic reconstruction of midbrain dopamine pathways using human pluripotent stem cells.

N Moriarty, CW Gantner, CPJ Hunt, CM Ermine… - Cell Stem …, 2022 - europepmc.org
Midbrain dopamine (mDA) neurons can be replaced in patients with Parkinson's disease
(PD) in order to provide long-term improvement in motor functions. The limited capacity for …

A combined cell and gene therapy approach for homotopic reconstruction of midbrain dopamine pathways using human pluripotent stem cells

N Moriarty, CW Gantner, CPJ Hunt, CM Ermine… - Cell Stem Cell, 2022 - lup.lub.lu.se
Midbrain dopamine (mDA) neurons can be replaced in patients with Parkinson's disease
(PD) in order to provide long-term improvement in motor functions. The limited capacity for …

[HTML][HTML] A combined cell and gene therapy approach for homotopic reconstruction of midbrain dopamine pathways using human pluripotent stem cells

N Moriarty, CW Gantner, CPJ Hunt, CM Ermine… - Cell Stem Cell, 2022 - Elsevier
Midbrain dopamine (mDA) neurons can be replaced in patients with Parkinson's disease
(PD) in order to provide long-term improvement in motor functions. The limited capacity for …

[引用][C] A combined cell and gene therapy approach for homotopic reconstruction of midbrain dopamine pathways using human pluripotent stem cells

N Moriarty, CW Gantner, CPJ Hunt, CM Ermine… - Cell Stem Cell, 2022 - cir.nii.ac.jp
A combined cell and gene therapy approach for homotopic reconstruction of midbrain
dopamine pathways using human pluripotent stem cells | CiNii Research CiNii 国立情報学 …

A combined cell and gene therapy approach for homotopic reconstruction of midbrain dopamine pathways using human pluripotent stem cells

N Moriarty, CW Gantner, CPJ Hunt… - Cell stem …, 2022 - pubmed.ncbi.nlm.nih.gov
Midbrain dopamine (mDA) neurons can be replaced in patients with Parkinson's disease
(PD) in order to provide long-term improvement in motor functions. The limited capacity for …

[HTML][HTML] A combined cell and gene therapy approach for homotopic reconstruction of midbrain dopamine pathways using human pluripotent stem cells

N Moriarty, CW Gantner, CPJ Hunt, CM Ermine… - Cell Stem Cell, 2022 - cell.com
Midbrain dopamine (mDA) neurons can be replaced in patients with Parkinson's disease
(PD) in order to provide long-term improvement in motor functions. The limited capacity for …

A combined cell and gene therapy approach for homotopic reconstruction of midbrain dopamine pathways using human pluripotent stem cells

N Moriarty, CW Gantner, CPJ Hunt, CM Ermine… - Cell Stem …, 2022 - portal.research.lu.se
Midbrain dopamine (mDA) neurons can be replaced in patients with Parkinson's disease
(PD) in order to provide long-term improvement in motor functions. The limited capacity for …

A combined cell and gene therapy approach for homotopic reconstruction of midbrain dopamine pathways using human pluripotent stem cells

N Moriarty, CW Gantner, CPJ Hunt, CM Ermine… - paper.sciencenet.cn
Midbrain dopamine (mDA) neurons can be replaced in patients with Parkinson's disease
(PD) in order to provide long-term improvement in motor functions. The limited capacityfor …